Protection of mice from Mycobacterium avium infection by recombinant interleukin-12.
AUTOR(ES)
Kobayashi, K
RESUMO
Treatment with interleukin-12 (IL-12) significantly reduced the number of viable bacteria in mice infected with Mycobacterium avium. IL-12 itself, however, could not inhibit directly mycobacterial growth in vitro. IL-12 exerts antimycobacterial activity in vivo with a low level of toxicity, possibly by enhancing the host defense against the infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162744Documentos Relacionados
- Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.
- Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.
- Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12.
- Intramacrophage growth of Mycobacterium avium during infection of mice.
- Interleukin-2 and Loss of Immunity in Experimental Mycobacterium avium Infection
